Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 15,000 | |||
25 mg | 在庫あり | ¥ 24,000 | |||
50 mg | 在庫あり | ¥ 39,000 | |||
100 mg | 在庫あり | ¥ 58,000 | |||
500 mg | 在庫あり | ¥ 121,500 |
説明 | Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants. |
植物由来 |
別名 | LGM2605 |
分子量 | 686.704 |
分子式 | C32H46O16 |
CAS No. | 158932-33-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 91 mg/mL(132.5 mM)
DMSO: 125 mg/mL(182.03 mM)
Pyridine, Methanol: Soluble
H2O: 50 mg/mL (72.8 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Secoisolariciresinol diglucoside 158932-33-3 Immunology/Inflammation ROS LGM 2605 LGM2605 LGM-2605 Inhibitor inhibitor inhibit